Program Book

Recommendations

Info

Patronage Agencia Nacional de Promoción Científica y Tecnológica 4
Table of Contents Welcome address Keynote Lectures The Stallard Lecture General Information Buenos Aires MAP <strong>Program</strong> Overview Research Day Presentations Abstracts Retinoblastoma Presentations Abstracts Posters Poster Abstracts Eyelid, Conjuntiva, Orbit and Other Intraocular Tumors Presentations Rapid Fire Cases Posters Abstracts Rapid Fire Abstracts Poster Abstracts Uveal Melanoma Presentations Posters Abstracts Posters Abstracts Index (First Authors) 5 7 8 9 10 12 13 15 18 29 35 32 48 61 62 65 67 75 83 91 94 96 108 118
Page 1 and 2: XV th NH City Hotel and Tower Boliv
Page 3: List of Congress Meetings of the In
Page 8 and 9: Keynote Lectures Lymphoma of the oc
Page 10 and 11: The venue for the Biannual Meeting
Page 12 and 13: Buenos Aires Downtown MAP 12 Venue
Page 15 and 16: MORNING 8.30-10.10 Papers (Moderato
Page 17 and 18: 50 RES 26 USING THE GLYCOLYTIC INHI
Page 19 and 20: 2226 RES 4 NOTCH SIGNALING PROMOTES
Page 21 and 22: a reduction in the number of living
Page 23 and 24: array further detected copy number
Page 25 and 26: 615 RES 21 TRB2 AND SKP2 IN THE RET
Page 27: following treatment with 2-fluorode
Page 30 and 31: 1909 Rb14 RESULTS OF PATIENTS WITH
Page 32 and 33: Posters Retinoblastoma 2006 RBp100
Page 34 and 35: 120 RBp135 MANAGEMENT OF AN ECTOPIC
Page 36 and 37: After treatment, 10 patients lived
Page 38 and 39: Methods. Six cycles of carboplatin
Page 40 and 41: 1940 RB15 PROTON THERAPY FOR RECURR
Page 42 and 43: 4. Fluoroscopy for cannula placemen
Page 44 and 45: Methods. A retrospective chart revi
Page 46 and 47: Ruth A. Kleinerman1, Chu-ling Yu1,
Page 48 and 49: 2006 RBp100 RETINOBLASTOMA ASSESSME
Page 50 and 51: months. Mean delay between beginnin
Page 52 and 53: not associated with severity of RB.
Page 54 and 55:
Conclusions. During a ten-year peri
Page 56 and 57:
30 RBp127 TREATMENT MODULATION IN R
Page 58 and 59:
(follow-up 5 years). Two years afte
Page 61 and 62:
8.30-9.00 Poster presentations ECOp
Page 63 and 64:
Uvea (Moderators: B. Damato, M. Sag
Page 65 and 66:
Morning 8.30-9.00 Poster presentati
Page 67 and 68:
1621 EC1 EVALUATION OF THE “HEDGE
Page 69 and 70:
Purpose. Ocular surface squamous ne
Page 71 and 72:
(cargusale@yahoo.com) Oncology Serv
Page 73 and 74:
of the tissues most commonly affect
Page 75 and 76:
2128 RF1 RETINOBLASTOMA David H. Ab
Page 77 and 78:
Ocular Oncology Service, St Barthol
Page 79 and 80:
Arturo Irarrazaval, Pablo Cazon, Os
Page 81 and 82:
A CASE OF TEARING AND SWELLING OF T
Page 83 and 84:
1849 ECp101 FIVE CASES OF CARCINOMA
Page 85 and 86:
patients. The isolated involvement
Page 87 and 88:
exudative fluid from the hemangioma
Page 89:
maximum of 7 rituximab injections.
Page 92 and 93:
153 UM14 PHENO-GENOTYPIC IDENTIFICA
Page 94 and 95:
8.30-9.00 Poster presentations UMp1
Page 96 and 97:
2253 UM1 PRELIMINARY STUDY OF VASCU
Page 98 and 99:
Purpose. To determine the presence
Page 100 and 101:
gene expression profile of melanocy
Page 102 and 103:
the rarity of UM, timely completion
Page 104 and 105:
C. Metz, T. Gkika, W. Sauerwein, N.
Page 106 and 107:
Patients in the triamcinolone group
Page 108 and 109:
1350 Ump101 INDUCED EXPRESSION OF P
Page 110 and 111:
Purpose. To report the Results of R
Page 112 and 113:
1547 Ump113 LONG-TERM OBSERVATIONS
Page 114 and 115:
2038 Ump119 VALUE OF DOPPLER ANALYS
Page 116:
Methods. A total of 4070 patients w
Page 119:
First authors Naseripour, Masood No
show all

Program Book

Create successful ePaper yourself

Delete template?

Save as template?